Mindray Medical International Limited (MR) 26.87 $MR
Asia-Pacific Clinical Chemistry Market 2013-2018
M2 - Wed Dec 17, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz9p48/micro_market) has announced the addition of the "Micro Market Monitor: Asia-Pacific Clinical Chemistry Market" report to their offering. The market in this region is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1,047.2 million by 2018, at a CAGR of 16% from 2013 to 2018. The Asia-Pacific clinical chemistry market is growing due to the ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology, and finally, the geographical market expansion within emerging countries. The major changes in clinical chemistry have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, new technologies have enabled a better understanding of disease processes. The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview Companies Mentioned - Abbott Diagnostics Inc. - Beckman Coulter Inc. (Subsidiary Of Danaher Corporation) - Fujifilm Holdings Corporation - Hitachi Ltd - Horiba Ltd - Mindray Medical International Limited - Orthoclinical Diagnostics - Randox Laboratories - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific Inc. - Toshiba Corporation - Transasia Bio-Medicals Ltd. For more information visit http://www.researchandmarkets.com/research/mz...cro_market
DHR: 86.79 (-0.27), MR: 26.87 (+0.30)
Global Mammography Systems Market Forecast and Opportunity Assessment 2007 - 2020
M2 - Tue Dec 16, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/h2x2hm/global) has announced the addition of the "Global Mammography Systems Market Forecast and Opportunity Assessment, 2007 - 2020" report to their offering. The global mammography market is projected to be $2.8 billion by 2020 Breast cancer, one of the most common types of cancer affecting women worldwide, represents about a quarter of all cancer deaths in women. This high mortality indicates the unmet needs of patients diagnosed with breast cancer and has resulted in a surge in demand for mammography devices in developing countries and upgrade or replacement to digital mammography systems, Full Field Digital Mammography (FFDM) and 3-D mammography systems from analogue mammography systems in developed nations. Also, the acceptance of early diagnosis has increased among people as a result of enhanced breast cancer awareness, initiation of breast screening programs, evolution in technologies and steps to improve reimbursement policies by various governments. Yet factors like high risk of exposure to radiation, false diagnosis, uncomfortable procedure, risk of occurrence of interval cancer and lack of female technicians are restraining the market growth. Among mammography systems, digital mammography has the largest market in the US, Europe, Australia and Japan but it is relatively a newer technology for the underpenetrated markets for mammography, like the rest of the Asia Pacific. For the rest of APAC and other developing economies, FFDM systems would become major centers of growth in the longer run. Key Topics Covered: 1. Charts & Tables 2. Global Market for Mammography Systems Devices (2007-2020) 3. North America Market for Mammography Systems Devices (2007-2020) 4. US Market for Mammography Systems (2007-2020) 5. Canada Market for Mammography Systems (2007-2020) 6. Europe Market for Mammography Systems Devices (2007-2020) 7. France Market for Mammography Systems (2007-2020) 8. Germany Market for Mammography Systems (2007-2020) 9. Italy Market for Mammography Systems (2007-2020) 10. Spain Market for Mammography Systems (2007-2020) 11. Netherlands Market for Mammography Systems (2007-2020) 12. UK Market for Mammography Systems (2007-2020) 13. Bulgaria Market for Mammography Systems (2007-2020) 14. Russia Market for Mammography Systems (2007-2020) 15. Asia Pacific Market for Mammography Systems Devices (2007-2020) 16. Australia Market for Mammography Systems (2007-2020) 17. China Market for Mammography Systems (2007-2020) 18. India Market for Mammography Systems (2007-2020) 19. Japan Market for Mammography Systems (2007-2020) 20. Recent Events and Developments 21. Company and Product Profiles - Carestream Health - Esaote - FUJIFILM Holdings Corp. - GE Healthcare - Hitachi Ltd. - Hologic Inc. - Internazionale Medico Scientifica Srl. - Mindray Medical International Limited - PerkinElmer Inc. - Philips Healthcare - Planmed Oy - Sectra AB - Shimadzu Corp. - Siemens Healthcare - SonoCine Inc. - Toshiba Medical Systems Corp. For more information visit http://www.researchandmarkets.com/research/h2x2hm/global
MR: 26.87 (+0.30), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
China Medical Monitor Industry Report 2014-2017
M2 - Tue Dec 16, 8:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/bwgnhc/china_medical) has announced the addition of the "China Medical Monitor Industry Report, 2014-2017" report to their offering. During 2007-2013, the market size grew at a CAGR of 21.5%, to RMB4.69 billion in 2013. However, the medical monitor penetration in China was still at a relatively lower level, at 26.5% in 2013, far below the US level of 80%, reflecting great development potential. It is projected that by 2017 the market size of medical monitor industry in China will exceed RMB10 billion. At present, most medical monitor enterprises in China are still very small and have weak R&D capabilities, and the market is dominated by Mindray, Philips, and GE, which occupy a combined share of roughly 80% in China medical monitor market. Moreover, Philips and GE enjoy absolute superiority in Chinese market of medium and high-end monitors. But under the backdrop of medical reform in China, foreign companies are also expanding their presence in medium and low-end market. For example, GE planned to raise the proportion of medium and high-end monitors and low-end ones in China 50%:50% by 2015. As a leader in China's medical monitor industry, Mindray took a 37% market share at home in 2013. Currently, the company is stepping up the expansion in China's high-end monitor market. Compared with medical imaging system and in-vitro Diagnostics, however, Mindray's revenue from monitoring products showed a slowdwon in growth rate, with the revenue proportion falling from 44% in 2009 to 36% in the first three quarters of 2014. Key Topics Covered: 1. Overview of Medical Monitor Industry 2. Status Quo of Medical Monitor Industry 3. Development Environment of Medical Monitors in China 4. Major Medical Monitor Enterprises 5. Summary and Forecast Companies Mentioned - Beijing Choice Electronic Tech Co., Ltd - EDAN Instruments, Inc. - Fukuda Denshi Co., Ltd. - GE - Guangdong Biolight Meditech Co., Ltd. - Mindray Medical International Limited - Nihon Kohden Corp. - Philips - Shenzhen Creative Industry Co., Ltd. - Tianrong Medical & Communication Equipment Co.,Ltd For more information visit http://www.researchandmarkets.com/research/bw...na_medical
MR: 26.87 (+0.30)
Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting
PR Newswire - Fri Dec 12, 4:00PM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10, 2014.
MR: 26.87 (+0.30)
Downgrade Alert for Mindray Medical International (MR)
Comtex SmarTrend(R) - Fri Dec 12, 6:58AM CST
Mindray Medical International (NYSE:MR) was downgraded from Equal Weight to Underweight at Morgan Stanley today. The stock closed yesterday at $28.19 on volume of 633,000 shares, below average daily volume of 737,000. In the past 52 weeks, Mindray Medical International share prices have been bracketed by a low of $27.52 and a high of $41.92 and closed yesterday at $28.19, 2% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 0.3%.
MR: 26.87 (+0.30)
Patient Monitoring Global Market Outlook, 2020
M2 - Wed Dec 10, 2:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/b3lgds/patient) has announced the addition of the "Patient Monitoring Global Market Outlook, 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $23.9 billion by 2019 with North America commanding the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4.Patient Monitoring Market by Devices 6 Company Developments 7 Major Company Profiles - Abbott Laboratories - Siemens Healthcare - Conmed - Covidien - Drager Medical Gmbh - Ge Healthcare - Johnson & Johnson, Inc. - Mindray Medical International Limited - Roche Diagnostics Limited - Royal Philips Healthcare For more information visit http://www.researchandmarkets.com/research/b3lgds/patient
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MR: 26.87 (+0.30)
Ultrasound Market Worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Tue Dec 09, 2:50AM CST
The global ultrasound market was dominated by General Electric Company (U.S.) in 2013, followed by Koninklijke Philips N.V. (The Netherlands). Other players include FUJIFILM Holdings Corporation (Japan), Mindray Medical International Limited (China), Hitachi Ltd. (Japan), Samsung Electronics Co. Ltd. (South Korea), Siemens AG (Germany), and Toshiba Corporation (Japan).
MR: 26.87 (+0.30)
Ultrasound Market by Diagnostic Ultrasound, Therapeutic Ultrasound, Products, Applications - Global Forecast to 2019
M2 - Thu Nov 20, 5:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/6hw9dq/ultrasound_market) has announced the addition of the "Ultrasound Market by Diagnostic Ultrasound, Therapeutic Ultrasound, Products, Applications - Global Forecast to 2019" report to their offering. The global ultrasound market is estimated to grow at a CAGR of 5.1% from 2014 to 2019 Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the ultrasound market in 2014, Asia-Pacific is poised to grow at the highest CAGR of 5.5% in the next five years. Factors such as the rapidly increasing aging population, growing focus of multinational companies on emerging markets, improvements and modernization of healthcare infrastructure, government initiatives to have advanced imaging systems at public healthcare facilities, and high incidences of cancer cases in this region are propelling the growth of this market. Market growth is driven by factors such as development of technologically advanced systems; rapid growth in aging population with high risk of target diseases; rising incidences of cardiovascular diseases and cancer cases; growing demand for minimally invasive treatment procedures; and increasing public-private investments. However, factors such as technological limitations of ultrasound, dearth of skilled and experienced sonographers, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. Moreover, emerging markets (such as China, India, Brazil, and Mexico); miniaturization of ultrasound devices and growing number of hospitals and surgical centers are creating opportunities for market growth. In this report, the global ultrasound market has been segmented on the basis of technology [diagnostic ultrasound (2D, 3D & 4D ultrasound, and Doppler imaging) and therapeutic ultrasound (high-intensity focused ultrasound (HIFU), and extracorporeal shock wave lithotripsy (ESWL))], product [by type of display (black & white, and color ultrasound), and portability (trolley/cart-based and compact/handheld ultrasound devices)], application [radiology/general imaging, urology, obstetrics/gynecology, vascular, cardiology, and others (hepatology, surgery, and breast ultrasound)]. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Ultrasound Market, By Technology 8 Global Ultrasound Market, By Product 9 Global Ultrasound Market, By Application 10 Global Ultrasound Market, By Geography 11 Competitive Landscape 12 Company Profiles - Analogic Corporation - Esaote S.P.A - Fujifilm Holdings Corporation - GE Healthcare (A Division Of General Electric Company) - Hitachi Medical Corporation (A Wholly Owned Subsidiary Of Hitachi Ltd.) - Mindray Medical International Ltd. - Philips Healthcare (A Division Of Koninklijke Philips N.V.) - Samsung Medison Co. Ltd. (An Affiliate Of Samsung Electronics Co. Ltd.) - Siemens Healthcare (A Subsidiary Of Siemens Ag) - Toshiba Medical Systems Corporation (A Subsidiary Of Toshiba Corporation) For more information visit http://www.researchandmarkets.com/research/6h...und_market
GE: 25.83 (-0.05), ALOG: 86.43 (+0.32), MR: 26.87 (+0.30)
Global Defibrillator Market 2014-2018: Key Vendors are BIOTRONIK, Boston Scientific, Medtronic, Phillips Healthcare and St. Jude Medical
M2 - Wed Nov 19, 3:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/gfq4pf/global) has announced the addition of the "Global Defibrillator Market 2014-2018" report to their offering. One of the key trends in this market is the increase in the use of multifunction defibrillators. Other parameters that can be monitored with the help of the current multifunctional defibrillators include SPO2, blood pressure, and CO2. According to the report, one of the key drivers of this market is the increase in the incidence of cardiac disorders. Cardiac disorders are caused by the increase in cholesterol levels, excessive smoking, and hypertension while a defibrillator is a life-saving device for a person undergoing sudden cardiac arrest. Further, the report states that one of the major challenges that the market faces is the presence of safety concerns associated with the use of defibrillators. Defibrillators such as ICDs are implanted through the MI procedure, which poses the risks of lead dislodgement, movement of the ICD generator out of its proper position, inappropriate shocks leading to pain or other complications, and psychological trauma. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Product 08. Market Segmentation by End-users 09. Geographical Segmentation 10. Key Leading Countries 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. 17. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - BIOTRONIK - Boston Scientific - Medtronic - Phillips Healthcare - St. Jude Medical - Asahi Kasei - Defibtech - Exactech - GE Healthcare - Heartsine Technologies - Mindray Medical International - Nihon Kohden - Physio-Control - Schiller - Sorin For more information visit http://www.researchandmarkets.com/research/gfq4pf/global
BSX: 13.13 (+0.07), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), MR: 26.87 (+0.30)
Global Clinical Chemistry Analyzer (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals) Market - Forecast to 2019
M2 - Fri Nov 14, 5:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/jzzrg4/clinical) has announced the addition of the "Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019" report to their offering. Clinical chemistry analyzers are the most widely used equipments in clinical laboratories. A large quantity of reagents and other consumables are required for various types of tests. Basic metabolic panel tests are the largest test segment for the clinical chemistry analyzer market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019. Growth in the basic metabolic panel tests, aided by growing trends of preventive medicine and increasing incidence in lifestyle disease will drive the growth of the market. This report segments the global clinical chemistry analyzer market into analyzers, reagents and other products. The market is further sub segmented into Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), Very large (2,000 Tests/H). The clinical chemistry reagents market is sub segmented into calibrators, controls, standards and other reagents. The major players in the clinical chemistry analyzer market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup (France), Mindray (China), Horiba (Japan). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Clinical Chemistry Analyzers Market, By Product 8 Clinical Chemistry Analyzers Market, By Test 9 Clinical Chemistry Analyzers Market, By End Users 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles 13 Appendix Companies Mentioned: - Abbott Laboratories - Danaher Corporation - Elitech - F. Hoffmann-La Roche - Horiba - Johnson & Johnson - Mindray Medical International Limited - Randox Laboratories - Siemens - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/jzzrg4/clinical
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), DHR: 86.79 (-0.27), MR: 26.87 (+0.30)
Mindray to Hold Annual General Meeting in Hong Kong on December 10, 2014
PR Newswire - Thu Nov 13, 5:00AM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will hold its 2014 annual general meeting of record at the Company's Hong Kong office (FLAT/RM 15-16 BLK 1 11/F, Grand Century, 193 Prince Edward West Road, Mongkok KL, Hong Kong) at 11:00 a.m. on December 10, 2013 Beijing/Hong Kong Time (10:00 p.m. on December 9, 2013 U.S. Eastern Time). The shareholder record date is November 7, 2014.
MR: 26.87 (+0.30)
The Zacks Analyst Blog Highlights: Alibaba Group Holding, Mindray Medical International, Changyou.com, NetEase and China Mobile
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Alibaba Group Holding Ltd. (NYSE:BABA-Free Report), Mindray Medical International Ltd. (NYSE:MR-Free Report), Changyou.com Ltd. (Nasdaq:CYOU-Free Report), NetEase, Inc. (Nasdaq:NTES-Free Report) and China Mobile Ltd. (NYSE:CHL-Free Report).
CYOU: 25.85 (+0.42), MR: 26.87 (+0.30), BABA: 105.95 (+0.43)
China Stock Roundup: Alibaba Misses, Mindray Meets Estimates - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Nov 06, 9:41AM CST
Markets experienced another largely positive week, indicating that the economy is responding positively to the government's reform agenda.
WB: 14.75 (-0.03), NTES: 101.31 (+0.90), CHL: 59.15 (-0.02), CYOU: 25.85 (+0.42), MR: 26.87 (+0.30), BABA: 105.95 (+0.43)
Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 38.46 (+0.13), FLDM: 32.31 (+0.30), ANGO: 19.19 (+0.33), MR: 26.87 (+0.30)
Mindray Medical International's (MR) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:13PM CST
MR: 26.87 (+0.30)
Mindray Medical International Limited (MR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 6:55AM CST
MR: 26.87 (+0.30)
Mindray Medical beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:02PM CST
MR: 26.87 (+0.30)
Mindray Announces Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 03, 4:00PM CST
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014.
MR: 26.87 (+0.30)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 18.21 (+0.11), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), GSK: 42.85 (+0.11), MR: 26.87 (+0.30), SEM: 14.67 (+0.27), PDLI: 7.61 (unch), SNN: 38.18 (+0.14), AZN: 70.44 (+0.26), MRK: 57.46 (+0.25), STJ: 66.67 (+0.67), TRIB: 16.98 (-0.13), ABBV: 66.21 (+1.86), THRX: 14.55 (+0.22), SNY: 46.35 (+0.50)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 61.26 (-0.41), HLF: 37.98 (+0.20), EGAN: 5.12 (+0.05), CUTR: 9.98 (-0.01), DXPE: 51.55 (-0.41), AEIS: 24.18 (-0.01), NOR: 3.49 (-0.04), KBR: 17.00 (-0.13), SGY: 17.83 (-0.52), RTEC: 10.16 (+0.01), PKT: 7.40 (+0.11), OGS: 42.29 (+0.55), BKH: 53.53 (+0.45), KAMN: 40.17 (-0.14), EOX: 1.33 (+0.05), MR: 26.87 (+0.30), RKUS: 11.65 (+0.01), LCI: 42.29 (+1.79), NBIX: 21.33 (+0.09), PQ: 3.87 (+0.02), RBC: 75.58 (-0.09), CHGG: 6.91 (-0.08), AIG: 56.28 (-0.16), MRO: 28.36 (-0.34), GRT: 13.84 (+0.02), EPAM: 48.84 (+0.33), CKP: 13.71 (unch), SBRA: 30.25 (-0.06), MDU: 23.25 (+0.04), NTRI: 19.66 (+0.02), ELNK: 4.30 (-0.05), EQC: 25.55 (-0.08), CVD: 103.73 (+0.02), IART: 53.68 (+0.32), FN: 17.51 (-0.17), APL: 26.55 (-0.05), BDE: 8.38 (+0.24), AGU: 95.91 (+0.20), PLOW: 21.71 (-0.20), REG: 64.30 (-0.04), QLYS: 38.89 (-0.05), GALE: 1.49 (-0.02), ANV: 0.88 (+0.02), ININ: 46.94 (-0.33), FTR: 6.76 (-0.02), GTY: 18.13 (-0.08), MCEP: 6.07 (-0.12), CYH: 55.36 (+0.37), SKH: 8.73 (-0.02), ACXM: 20.76 (+0.06), PL: 69.62 (-0.03), RLD: 11.35 (+0.02), CXW: 37.94 (+0.05), SALE: 14.83 (+0.19), ENH: 59.60 (-0.55), CRK: 7.01 (-0.20), AMTG: 16.16 (-0.09), OTTR: 31.39 (+0.14), NLS: 14.58 (-0.17)
Asia-Pacific Clinical Chemistry Market 2013-2018
M2 - Wed Dec 17, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz9p48/micro_market) has announced the addition of the "Micro Market Monitor: Asia-Pacific Clinical Chemistry Market" report to their offering. The market in this region is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1,047.2 million by 2018, at a CAGR of 16% from 2013 to 2018. The Asia-Pacific clinical chemistry market is growing due to the ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology, and finally, the geographical market expansion within emerging countries. The major changes in clinical chemistry have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, new technologies have enabled a better understanding of disease processes. The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview Companies Mentioned - Abbott Diagnostics Inc. - Beckman Coulter Inc. (Subsidiary Of Danaher Corporation) - Fujifilm Holdings Corporation - Hitachi Ltd - Horiba Ltd - Mindray Medical International Limited - Orthoclinical Diagnostics - Randox Laboratories - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific Inc. - Toshiba Corporation - Transasia Bio-Medicals Ltd. For more information visit http://www.researchandmarkets.com/research/mz...cro_market
DHR: 86.79 (-0.27), MR: 26.87 (+0.30)
Global Mammography Systems Market Forecast and Opportunity Assessment 2007 - 2020
M2 - Tue Dec 16, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/h2x2hm/global) has announced the addition of the "Global Mammography Systems Market Forecast and Opportunity Assessment, 2007 - 2020" report to their offering. The global mammography market is projected to be $2.8 billion by 2020 Breast cancer, one of the most common types of cancer affecting women worldwide, represents about a quarter of all cancer deaths in women. This high mortality indicates the unmet needs of patients diagnosed with breast cancer and has resulted in a surge in demand for mammography devices in developing countries and upgrade or replacement to digital mammography systems, Full Field Digital Mammography (FFDM) and 3-D mammography systems from analogue mammography systems in developed nations. Also, the acceptance of early diagnosis has increased among people as a result of enhanced breast cancer awareness, initiation of breast screening programs, evolution in technologies and steps to improve reimbursement policies by various governments. Yet factors like high risk of exposure to radiation, false diagnosis, uncomfortable procedure, risk of occurrence of interval cancer and lack of female technicians are restraining the market growth. Among mammography systems, digital mammography has the largest market in the US, Europe, Australia and Japan but it is relatively a newer technology for the underpenetrated markets for mammography, like the rest of the Asia Pacific. For the rest of APAC and other developing economies, FFDM systems would become major centers of growth in the longer run. Key Topics Covered: 1. Charts & Tables 2. Global Market for Mammography Systems Devices (2007-2020) 3. North America Market for Mammography Systems Devices (2007-2020) 4. US Market for Mammography Systems (2007-2020) 5. Canada Market for Mammography Systems (2007-2020) 6. Europe Market for Mammography Systems Devices (2007-2020) 7. France Market for Mammography Systems (2007-2020) 8. Germany Market for Mammography Systems (2007-2020) 9. Italy Market for Mammography Systems (2007-2020) 10. Spain Market for Mammography Systems (2007-2020) 11. Netherlands Market for Mammography Systems (2007-2020) 12. UK Market for Mammography Systems (2007-2020) 13. Bulgaria Market for Mammography Systems (2007-2020) 14. Russia Market for Mammography Systems (2007-2020) 15. Asia Pacific Market for Mammography Systems Devices (2007-2020) 16. Australia Market for Mammography Systems (2007-2020) 17. China Market for Mammography Systems (2007-2020) 18. India Market for Mammography Systems (2007-2020) 19. Japan Market for Mammography Systems (2007-2020) 20. Recent Events and Developments 21. Company and Product Profiles - Carestream Health - Esaote - FUJIFILM Holdings Corp. - GE Healthcare - Hitachi Ltd. - Hologic Inc. - Internazionale Medico Scientifica Srl. - Mindray Medical International Limited - PerkinElmer Inc. - Philips Healthcare - Planmed Oy - Sectra AB - Shimadzu Corp. - Siemens Healthcare - SonoCine Inc. - Toshiba Medical Systems Corp. For more information visit http://www.researchandmarkets.com/research/h2x2hm/global
MR: 26.87 (+0.30), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
China Medical Monitor Industry Report 2014-2017
M2 - Tue Dec 16, 8:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/bwgnhc/china_medical) has announced the addition of the "China Medical Monitor Industry Report, 2014-2017" report to their offering. During 2007-2013, the market size grew at a CAGR of 21.5%, to RMB4.69 billion in 2013. However, the medical monitor penetration in China was still at a relatively lower level, at 26.5% in 2013, far below the US level of 80%, reflecting great development potential. It is projected that by 2017 the market size of medical monitor industry in China will exceed RMB10 billion. At present, most medical monitor enterprises in China are still very small and have weak R&D capabilities, and the market is dominated by Mindray, Philips, and GE, which occupy a combined share of roughly 80% in China medical monitor market. Moreover, Philips and GE enjoy absolute superiority in Chinese market of medium and high-end monitors. But under the backdrop of medical reform in China, foreign companies are also expanding their presence in medium and low-end market. For example, GE planned to raise the proportion of medium and high-end monitors and low-end ones in China 50%:50% by 2015. As a leader in China's medical monitor industry, Mindray took a 37% market share at home in 2013. Currently, the company is stepping up the expansion in China's high-end monitor market. Compared with medical imaging system and in-vitro Diagnostics, however, Mindray's revenue from monitoring products showed a slowdwon in growth rate, with the revenue proportion falling from 44% in 2009 to 36% in the first three quarters of 2014. Key Topics Covered: 1. Overview of Medical Monitor Industry 2. Status Quo of Medical Monitor Industry 3. Development Environment of Medical Monitors in China 4. Major Medical Monitor Enterprises 5. Summary and Forecast Companies Mentioned - Beijing Choice Electronic Tech Co., Ltd - EDAN Instruments, Inc. - Fukuda Denshi Co., Ltd. - GE - Guangdong Biolight Meditech Co., Ltd. - Mindray Medical International Limited - Nihon Kohden Corp. - Philips - Shenzhen Creative Industry Co., Ltd. - Tianrong Medical & Communication Equipment Co.,Ltd For more information visit http://www.researchandmarkets.com/research/bw...na_medical
MR: 26.87 (+0.30)
Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting
PR Newswire - Fri Dec 12, 4:00PM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10, 2014.
MR: 26.87 (+0.30)
Downgrade Alert for Mindray Medical International (MR)
Comtex SmarTrend(R) - Fri Dec 12, 6:58AM CST
Mindray Medical International (NYSE:MR) was downgraded from Equal Weight to Underweight at Morgan Stanley today. The stock closed yesterday at $28.19 on volume of 633,000 shares, below average daily volume of 737,000. In the past 52 weeks, Mindray Medical International share prices have been bracketed by a low of $27.52 and a high of $41.92 and closed yesterday at $28.19, 2% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 0.3%.
MR: 26.87 (+0.30)
Patient Monitoring Global Market Outlook, 2020
M2 - Wed Dec 10, 2:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/b3lgds/patient) has announced the addition of the "Patient Monitoring Global Market Outlook, 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $23.9 billion by 2019 with North America commanding the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4.Patient Monitoring Market by Devices 6 Company Developments 7 Major Company Profiles - Abbott Laboratories - Siemens Healthcare - Conmed - Covidien - Drager Medical Gmbh - Ge Healthcare - Johnson & Johnson, Inc. - Mindray Medical International Limited - Roche Diagnostics Limited - Royal Philips Healthcare For more information visit http://www.researchandmarkets.com/research/b3lgds/patient
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MR: 26.87 (+0.30)
Ultrasound Market Worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Tue Dec 09, 2:50AM CST
The global ultrasound market was dominated by General Electric Company (U.S.) in 2013, followed by Koninklijke Philips N.V. (The Netherlands). Other players include FUJIFILM Holdings Corporation (Japan), Mindray Medical International Limited (China), Hitachi Ltd. (Japan), Samsung Electronics Co. Ltd. (South Korea), Siemens AG (Germany), and Toshiba Corporation (Japan).
MR: 26.87 (+0.30)
Ultrasound Market by Diagnostic Ultrasound, Therapeutic Ultrasound, Products, Applications - Global Forecast to 2019
M2 - Thu Nov 20, 5:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/6hw9dq/ultrasound_market) has announced the addition of the "Ultrasound Market by Diagnostic Ultrasound, Therapeutic Ultrasound, Products, Applications - Global Forecast to 2019" report to their offering. The global ultrasound market is estimated to grow at a CAGR of 5.1% from 2014 to 2019 Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the ultrasound market in 2014, Asia-Pacific is poised to grow at the highest CAGR of 5.5% in the next five years. Factors such as the rapidly increasing aging population, growing focus of multinational companies on emerging markets, improvements and modernization of healthcare infrastructure, government initiatives to have advanced imaging systems at public healthcare facilities, and high incidences of cancer cases in this region are propelling the growth of this market. Market growth is driven by factors such as development of technologically advanced systems; rapid growth in aging population with high risk of target diseases; rising incidences of cardiovascular diseases and cancer cases; growing demand for minimally invasive treatment procedures; and increasing public-private investments. However, factors such as technological limitations of ultrasound, dearth of skilled and experienced sonographers, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. Moreover, emerging markets (such as China, India, Brazil, and Mexico); miniaturization of ultrasound devices and growing number of hospitals and surgical centers are creating opportunities for market growth. In this report, the global ultrasound market has been segmented on the basis of technology [diagnostic ultrasound (2D, 3D & 4D ultrasound, and Doppler imaging) and therapeutic ultrasound (high-intensity focused ultrasound (HIFU), and extracorporeal shock wave lithotripsy (ESWL))], product [by type of display (black & white, and color ultrasound), and portability (trolley/cart-based and compact/handheld ultrasound devices)], application [radiology/general imaging, urology, obstetrics/gynecology, vascular, cardiology, and others (hepatology, surgery, and breast ultrasound)]. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Ultrasound Market, By Technology 8 Global Ultrasound Market, By Product 9 Global Ultrasound Market, By Application 10 Global Ultrasound Market, By Geography 11 Competitive Landscape 12 Company Profiles - Analogic Corporation - Esaote S.P.A - Fujifilm Holdings Corporation - GE Healthcare (A Division Of General Electric Company) - Hitachi Medical Corporation (A Wholly Owned Subsidiary Of Hitachi Ltd.) - Mindray Medical International Ltd. - Philips Healthcare (A Division Of Koninklijke Philips N.V.) - Samsung Medison Co. Ltd. (An Affiliate Of Samsung Electronics Co. Ltd.) - Siemens Healthcare (A Subsidiary Of Siemens Ag) - Toshiba Medical Systems Corporation (A Subsidiary Of Toshiba Corporation) For more information visit http://www.researchandmarkets.com/research/6h...und_market
GE: 25.83 (-0.05), ALOG: 86.43 (+0.32), MR: 26.87 (+0.30)
Global Defibrillator Market 2014-2018: Key Vendors are BIOTRONIK, Boston Scientific, Medtronic, Phillips Healthcare and St. Jude Medical
M2 - Wed Nov 19, 3:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/gfq4pf/global) has announced the addition of the "Global Defibrillator Market 2014-2018" report to their offering. One of the key trends in this market is the increase in the use of multifunction defibrillators. Other parameters that can be monitored with the help of the current multifunctional defibrillators include SPO2, blood pressure, and CO2. According to the report, one of the key drivers of this market is the increase in the incidence of cardiac disorders. Cardiac disorders are caused by the increase in cholesterol levels, excessive smoking, and hypertension while a defibrillator is a life-saving device for a person undergoing sudden cardiac arrest. Further, the report states that one of the major challenges that the market faces is the presence of safety concerns associated with the use of defibrillators. Defibrillators such as ICDs are implanted through the MI procedure, which poses the risks of lead dislodgement, movement of the ICD generator out of its proper position, inappropriate shocks leading to pain or other complications, and psychological trauma. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Product 08. Market Segmentation by End-users 09. Geographical Segmentation 10. Key Leading Countries 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. 17. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - BIOTRONIK - Boston Scientific - Medtronic - Phillips Healthcare - St. Jude Medical - Asahi Kasei - Defibtech - Exactech - GE Healthcare - Heartsine Technologies - Mindray Medical International - Nihon Kohden - Physio-Control - Schiller - Sorin For more information visit http://www.researchandmarkets.com/research/gfq4pf/global
BSX: 13.13 (+0.07), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), MR: 26.87 (+0.30)
Global Clinical Chemistry Analyzer (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals) Market - Forecast to 2019
M2 - Fri Nov 14, 5:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/jzzrg4/clinical) has announced the addition of the "Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019" report to their offering. Clinical chemistry analyzers are the most widely used equipments in clinical laboratories. A large quantity of reagents and other consumables are required for various types of tests. Basic metabolic panel tests are the largest test segment for the clinical chemistry analyzer market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019. Growth in the basic metabolic panel tests, aided by growing trends of preventive medicine and increasing incidence in lifestyle disease will drive the growth of the market. This report segments the global clinical chemistry analyzer market into analyzers, reagents and other products. The market is further sub segmented into Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), Very large (2,000 Tests/H). The clinical chemistry reagents market is sub segmented into calibrators, controls, standards and other reagents. The major players in the clinical chemistry analyzer market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup (France), Mindray (China), Horiba (Japan). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Clinical Chemistry Analyzers Market, By Product 8 Clinical Chemistry Analyzers Market, By Test 9 Clinical Chemistry Analyzers Market, By End Users 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles 13 Appendix Companies Mentioned: - Abbott Laboratories - Danaher Corporation - Elitech - F. Hoffmann-La Roche - Horiba - Johnson & Johnson - Mindray Medical International Limited - Randox Laboratories - Siemens - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/jzzrg4/clinical
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), DHR: 86.79 (-0.27), MR: 26.87 (+0.30)
Mindray to Hold Annual General Meeting in Hong Kong on December 10, 2014
PR Newswire - Thu Nov 13, 5:00AM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will hold its 2014 annual general meeting of record at the Company's Hong Kong office (FLAT/RM 15-16 BLK 1 11/F, Grand Century, 193 Prince Edward West Road, Mongkok KL, Hong Kong) at 11:00 a.m. on December 10, 2013 Beijing/Hong Kong Time (10:00 p.m. on December 9, 2013 U.S. Eastern Time). The shareholder record date is November 7, 2014.
MR: 26.87 (+0.30)
The Zacks Analyst Blog Highlights: Alibaba Group Holding, Mindray Medical International, Changyou.com, NetEase and China Mobile
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Alibaba Group Holding Ltd. (NYSE:BABA-Free Report), Mindray Medical International Ltd. (NYSE:MR-Free Report), Changyou.com Ltd. (Nasdaq:CYOU-Free Report), NetEase, Inc. (Nasdaq:NTES-Free Report) and China Mobile Ltd. (NYSE:CHL-Free Report).
CYOU: 25.85 (+0.42), MR: 26.87 (+0.30), BABA: 105.95 (+0.43)
China Stock Roundup: Alibaba Misses, Mindray Meets Estimates - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Nov 06, 9:41AM CST
Markets experienced another largely positive week, indicating that the economy is responding positively to the government's reform agenda.
WB: 14.75 (-0.03), NTES: 101.31 (+0.90), CHL: 59.15 (-0.02), CYOU: 25.85 (+0.42), MR: 26.87 (+0.30), BABA: 105.95 (+0.43)
Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 38.46 (+0.13), FLDM: 32.31 (+0.30), ANGO: 19.19 (+0.33), MR: 26.87 (+0.30)
Mindray Medical International's (MR) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:13PM CST
MR: 26.87 (+0.30)
Mindray Medical International Limited (MR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 6:55AM CST
MR: 26.87 (+0.30)
Mindray Medical beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:02PM CST
MR: 26.87 (+0.30)
Mindray Announces Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 03, 4:00PM CST
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014.
MR: 26.87 (+0.30)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 18.21 (+0.11), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), GSK: 42.85 (+0.11), MR: 26.87 (+0.30), SEM: 14.67 (+0.27), PDLI: 7.61 (unch), SNN: 38.18 (+0.14), AZN: 70.44 (+0.26), MRK: 57.46 (+0.25), STJ: 66.67 (+0.67), TRIB: 16.98 (-0.13), ABBV: 66.21 (+1.86), THRX: 14.55 (+0.22), SNY: 46.35 (+0.50)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 61.26 (-0.41), HLF: 37.98 (+0.20), EGAN: 5.12 (+0.05), CUTR: 9.98 (-0.01), DXPE: 51.55 (-0.41), AEIS: 24.18 (-0.01), NOR: 3.49 (-0.04), KBR: 17.00 (-0.13), SGY: 17.83 (-0.52), RTEC: 10.16 (+0.01), PKT: 7.40 (+0.11), OGS: 42.29 (+0.55), BKH: 53.53 (+0.45), KAMN: 40.17 (-0.14), EOX: 1.33 (+0.05), MR: 26.87 (+0.30), RKUS: 11.65 (+0.01), LCI: 42.29 (+1.79), NBIX: 21.33 (+0.09), PQ: 3.87 (+0.02), RBC: 75.58 (-0.09), CHGG: 6.91 (-0.08), AIG: 56.28 (-0.16), MRO: 28.36 (-0.34), GRT: 13.84 (+0.02), EPAM: 48.84 (+0.33), CKP: 13.71 (unch), SBRA: 30.25 (-0.06), MDU: 23.25 (+0.04), NTRI: 19.66 (+0.02), ELNK: 4.30 (-0.05), EQC: 25.55 (-0.08), CVD: 103.73 (+0.02), IART: 53.68 (+0.32), FN: 17.51 (-0.17), APL: 26.55 (-0.05), BDE: 8.38 (+0.24), AGU: 95.91 (+0.20), PLOW: 21.71 (-0.20), REG: 64.30 (-0.04), QLYS: 38.89 (-0.05), GALE: 1.49 (-0.02), ANV: 0.88 (+0.02), ININ: 46.94 (-0.33), FTR: 6.76 (-0.02), GTY: 18.13 (-0.08), MCEP: 6.07 (-0.12), CYH: 55.36 (+0.37), SKH: 8.73 (-0.02), ACXM: 20.76 (+0.06), PL: 69.62 (-0.03), RLD: 11.35 (+0.02), CXW: 37.94 (+0.05), SALE: 14.83 (+0.19), ENH: 59.60 (-0.55), CRK: 7.01 (-0.20), AMTG: 16.16 (-0.09), OTTR: 31.39 (+0.14), NLS: 14.58 (-0.17)
